Tag: Insulin
2012 to 2015 Saw Rise in U.S. Insulin Prices
However, introduction of new insulin products after 2015 was followed by substantial discounting practices that lowered net prices
FDA Clears New Insulin Pump and Algorithm-Based Software
Enhanced automatic insulin delivery system cleared for people with type 1 diabetes ≥6 years
DDW: Endoscopic Procedure May Eliminate Insulin Use in T2DM
Recellularization via electroporation therapy followed by GLP1-RA treatment resulted in elimination of insulin therapy for most patients
Sanofi Follows Lilly, Novo Nordisk in Cutting Insulin Prices
Sanofi is the third company to cut prices on its insulin products and cap out-of-pocket charges to $35 a month
Closed-Loop Glucose System Beneficial for Young Children With Type 1 Diabetes
Greater percentage of time with glucose level in target range seen for young children using closed-loop system
Novo Nordisk to Cut Insulin Prices by Up to 75 Percent
News follows similar move made by Eli Lilly, which said earlier this month that it will cut insulin prices by 70 percent
Eli Lilly to Slash Insulin Prices, Cap Monthly Out-of-Pocket Costs at $35
Company will cut its list price for Humalog 100 units/mL starting in the fourth quarter of 2023
2009 to 2018 Saw Increase in Total Expenditure for Insulin
Out-of-pocket cost of insulin increased from $1,678 to $2,800 per person per year in pre- to post-ACA period for uninsured population
Fully Closed-Loop Insulin Delivery System Improves Glucose Control in T2DM
Improved glucose control seen with no increase in hypoglycemia compared with standard insulin therapy
Guidelines Updated for Reducing Hypoglycemia Risk in Diabetes
Strong recommendations include use of glucagon preparations that do not need reconstitution, real-time CGM for those receiving multiple daily injections
